Newell William J

Sutro Biopharma, Inc. · CEO

Newell William J is listed in filings as CEO at Sutro Biopharma, Inc.. This profile follows SEC Form 4 activity through Mar 7, 2025, including 7 public disclosures. Recent filings connect the profile to Sutro Biopharma, Inc. (STRO). The current snapshot covers public activity from Mar 4, 2025 to Mar 7, 2025. Reported amounts are shown as $9.1K to $40.1K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

Data sources and methodology

Latest Trades

CompanyValueActionPriceCurrent Price
No direct insider buys or sells are available yet.